Emily Schmidt is the Director of Autologous Process & Analytical Development at Adaptimmune. Emily previously worked as an Associate Director and Line-Managing Principal Scientist in the same field. Before that, Emily was a Senior Scientist at Kennedy Institute of Rheumatology. Emily completed their PhD in Immunology at the University of Birmingham after obtaining a degree in Biochemistry from the University of Bath. Emily has also gained experience in cellular immunology at GlaxoSmithKline and target validation at AstraZeneca during their academic journey.
This person is not in the org chart
This person is not in any teams
This person is not in any offices